alexa Richard Scranton | VeroScience LLC
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
 
 

Richard Scranton

Vice President
Biography

Richard Scranton joined Pacira in November 2011. As Vice President, Medical Health Sciences, he currently oversees strategic direction on health outcomes and economic research, and directs programs that assist Pacira’s customers in realizing the value provided by Pacira’s innovative products. In addition, he oversees medical educational activities and directs strategic alliance activities. He also serves as a member of the executive leadership team, is in charge of public affairs activities, which includes legislative activity and advocacy, and is also the lead on health affairs relating to the Department of Defense.

Prior to joining Pacira, Dr. Scranton was Chief Medical Officer for VeroScience in Tiverton, RI. He earned a Master's Degree in Public Health, Clinical Epidemiology/Clinical Effectiveness from the Harvard School of Public Health and earned his MD from the Quillen College of Medicine at East Tennessee State University. He completed his residency in the U.S. Navy and was honorably discharged as lieutenant commander, continuing as an Assistant Professor at Harvard Medical School. He also holds a BA in Biology from the University of Tennessee.

Research Interest

Diabetes, Type 2 Diabetes, latest research on diabetes, diabetes lipid metabolism, medical diabetes,Gestational diabetes,Diabetes immunogenetics,Diabetes immunogenetics

Publications

Randomized Clinical Trial Assessing the Efficacy and Safety of Bromocriptine-QR when Added to Ongoing Thiazolidinedione Therapy in Patients with Type 2 Diabetes Mellitus

Hermes Florez, Richard Scranton, Wildon R. Farwell, Ralph A. DeFronzo, Michael Ezrokhi, J. Michael Gaziano and Anthony H. Cincotta

Research Article: J Diabetes Metab 2011, 2:142

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords